Phyllis Flomenberg

TitleProfessor
InstitutionThomas Jefferson University
DepartmentInfectious Diseases
Address1101 Market Street
Philadelphia PA 19107
Phone215-955-7785
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R01AI042842     (FLOMENBERG, PHYLLIS R)Jan 15, 1999 - Dec 31, 2001
    NIH
    HUMAN CTL RESPONSES TO ADENOVIRUS GENE THERAPY VECTORS
    Role: Principal Investigator

    R21AI059246     (FLOMENBERG, PHYLLIS R)Apr 15, 2004 - Mar 31, 2008
    NIH
    Human T Cell Responses to Vaccinia Vaccine
    Role: Principal Investigator

    R01AI067684     (FLOMENBERG, PHYLLIS RUDOLPH)Jan 1, 2006 - Dec 31, 2010
    NIH
    Immunotherapy of Adenovirus Infections in Stem Cell Transplnt Recipients
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Grosso D, Wagner JL, O'Connor A, Keck K, Huang Y, Wang ZX, Mehler H, Leiby B, Flomenberg P, Gergis U, Nikbakht N, Morris M, Karp JK, Peedin A, Flomenberg N. Safety and Feasibility of Third-Party Cytotoxic T Lymphocytes for High-Risk Patients with Covid-19. Blood Adv. 2024 Jun 17. PMID: 38885482.
      Citations:    
    2. Mrani AJ, Kuchera T, Strohl A, Laoteppitaks C, Flomenberg P, Phillips L. Stingray Impalement and Envenomation: Local Envenoming Causing Necrosis and Sepsis. Wilderness Environ Med. 2024 Jan 22; 10806032231223326. PMID: 38379482.
      Citations:    
    3. Sedlock C, Tokarczyk M, Sternlieb M, Flomenberg P. PICC-associated infection with Escherichia hermannii: A case report and review of the literature. IDCases. 2018; 13:4. PMID: 30181953.
      Citations:    
    4. Chen J, Flomenberg P. Letter to the editor - Nocardia identification. IDCases. 2018; 12:170. PMID: 29942783.
      Citations:    
    5. Chen J, Pan J, Filicko-O'Hara J, Kasner M, Flomenberg P. Disseminated Nocardia cyriacigeorgia causing pancreatitis in a haploidentical stem cell transplant recipient. IDCases. 2017; 9:73-76. PMID: 28706856.
      Citations:    
    6. Grosso D, Gaballa S, Alpdogan O, Carabasi M, Filicko-O'Hara J, Kasner M, Martinez-Outschoorn U, Wagner JL, O'Hara W, Rudolph S, Chervoneva I, Colombe B, Farley PC, Flomenberg P, Pro B, Sharma M, Shi W, Weiss M, Flomenberg N. A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage disease. Biol Blood Marrow Transplant. 2015 Apr; 21(4):646-52. PMID: 25542159.
      Citations:    
    7. Bruminhent J, Wang ZX, Hu C, Wagner J, Sunday R, Bobik B, Hegarty S, Keith S, Alpdogan S, Carabasi M, Filicko-O'Hara J, Flomenberg N, Kasner M, Outschoorn UM, Weiss M, Flomenberg P. Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014 Sep; 20(9):1329-34. PMID: 24792871.
      Citations:    
    8. Hu C, Sunday R, Bruminhent J, Bobik B, Wagner J, Weiss M, Flomenberg P, Wang ZX. Investigation of a Clostridium difficile cluster by multilocus sequence typing in a bone marrow transplant unit. Am J Infect Control. 2014 Jun; 42(6):691-3. PMID: 24690456.
      Citations:    
    9. Rao SB, Vasquez G, Harrop J, Maltenfort M, Stein N, Kaliyadan G, Klibert F, Epstein R, Sharan A, Vaccaro A, Flomenberg P. Risk factors for surgical site infections following spinal fusion procedures: a case-control study. Clin Infect Dis. 2011 Oct; 53(7):686-92. PMID: 21890772.
      Citations:    
    10. Grosso D, Carabasi M, Filicko-O'Hara J, Kasner M, Wagner JL, Colombe B, Cornett Farley P, O'Hara W, Flomenberg P, Werner-Wasik M, Brunner J, Mookerjee B, Hyslop T, Weiss M, Flomenberg N. A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing. Blood. 2011 Oct 27; 118(17):4732-9. PMID: 21868572.
      Citations:    
    11. Joshi A, Zhao B, Romanowski C, Rosen D, Flomenberg P. Comparison of human memory CD8 T cell responses to adenoviral early and late proteins in peripheral blood and lymphoid tissue. PLoS One. 2011; 6(5):e20068. PMID: 21637763.
      Citations:    
    12. Harrop JS, Sharan AD, Ratliff J, Prasad S, Jabbour P, Evans JJ, Veznedaroglu E, Andrews DW, Maltenfort M, Liebman K, Flomenberg P, Sell B, Baranoski AS, Fonshell C, Reiter D, Rosenwasser RH. Impact of a standardized protocol and antibiotic-impregnated catheters on ventriculostomy infection rates in cerebrovascular patients. Neurosurgery. 2010 Jul; 67(1):187-91; discussion 191. PMID: 20559105.
      Citations:    
    13. Gomme EA, Faul EJ, Flomenberg P, McGettigan JP, Schnell MJ. Characterization of a single-cycle rabies virus-based vaccine vector. J Virol. 2010 Mar; 84(6):2820-31. PMID: 20053743.
      Citations:    
    14. Filicko-O'Hara J, Grosso D, Flomenberg PR, Friedman TM, Brunner J, Drobyski W, Ferber A, Kakhniashvili I, Keever-Taylor C, Mookerjee B, Talano JA, Wagner JI, Korngold R, Flomenberg N. Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease. Biol Blood Marrow Transplant. 2009 Dec; 15(12):1609-19. PMID: 19744572.
      Citations:    
    15. Joshi A, Tang J, Kuzma M, Wagner J, Mookerjee B, Filicko J, Carabasi M, Flomenberg N, Flomenberg P. Adenovirus DNA polymerase is recognized by human CD8+ T cells. J Gen Virol. 2009 Jan; 90(Pt 1):84-94. PMID: 19088277.
      Citations:    
    16. Neofytos D, Ojha A, Mookerjee B, Wagner J, Filicko J, Ferber A, Dessain S, Grosso D, Brunner J, Flomenberg N, Flomenberg P. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant. 2007 Jan; 13(1):74-81. PMID: 17222755.
      Citations:    
    17. Tang J, Murtadha M, Schnell M, Eisenlohr LC, Hooper J, Flomenberg P. Human T-cell responses to vaccinia virus envelope proteins. J Virol. 2006 Oct; 80(20):10010-20. PMID: 17005679.
      Citations:    
    18. Tang J, Olive M, Pulmanausahakul R, Schnell M, Flomenberg N, Eisenlohr L, Flomenberg P. Human CD8+ cytotoxic T cell responses to adenovirus capsid proteins. Virology. 2006 Jul 5; 350(2):312-22. PMID: 16499941.
      Citations:    
    19. Tang J, Flomenberg P, Harshyne L, Kenyon L, Andrews DW. Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells. Clin Cancer Res. 2005 Jul 15; 11(14):5292-9. PMID: 16033848.
      Citations:    
    20. Kojaoghlanian T, Flomenberg P, Horwitz MS. The impact of adenovirus infection on the immunocompromised host. Rev Med Virol. 2003 May-Jun; 13(3):155-71. PMID: 12740831.
      Citations:    
    21. Olive M, Eisenlohr L, Flomenberg N, Hsu S, Flomenberg P. The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope. Hum Gene Ther. 2002 Jul 1; 13(10):1167-78. PMID: 12133270.
      Citations:    
    22. Flomenberg PR, Chen M, Horwitz MS. Sequence and genetic organization of adenovirus type 35 early region 3. J Virol. 1988 Nov; 62(11):4431-7. PMID: 3172347.
      Citations:    
    23. Flomenberg PR, Chen M, Horwitz MS. Characterization of a major histocompatibility complex class I antigen-binding glycoprotein from adenovirus type 35, a type associated with immunocompromised hosts. J Virol. 1987 Dec; 61(12):3665-71. PMID: 2960830.
      Citations:    
    24. Flomenberg PR, Chen M, Munk G, Horwitz MS. Molecular epidemiology of adenovirus type 35 infections in immunocompromised hosts. J Infect Dis. 1987 Jun; 155(6):1127-34. PMID: 3033089.
      Citations:    
    Flomenberg's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (123)
    Explore
    _
    Co-Authors (38)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _